Akèy › Kansè Ipofaringe › Maryland › Baltimore
Etid klinik pou Kansè Ipofaringe nan Baltimore, MD
4 etid pou Kansè Ipofaringe ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Ap rekriteFaz 1
- University of Maryland/Greenebaum Cancer Center, Baltimore
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Ap rekriteFaz 2
- Greater Baltimore Medical Center, Baltimore
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
- Greater Baltimore Medical Center, Baltimore
Etid Kansè Ipofaringe nan lòt vil
- Atlanta, GA6 etid
- Chicago, IL6 etid
- Richmond, VA5 etid
- Kansas City, MO5 etid
- Joliet, IL5 etid
- Milwaukee, WI5 etid
- Wausau, WI5 etid
- Cape Girardeau, MO5 etid
- Stevens Point, WI5 etid
- Peoria, IL5 etid
- Bloomington, IL5 etid
- Edison, NJ4 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Kansè (tout kalite)37 etid
- Kansè pankreyas31 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Obèsite26 etid
- Kansè vejik24 etid
- Ensifizyans kadyak24 etid
- Kansè ovè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.